Search

Atorvastatin-Loaded Oleic Acid Nanoglobules for Oral Administration: In Vitro Characterization and Biopharmaceutical Evaluation

Journal: Current Nanoscience
Volume: 9 Issue: 2 Year: 2013 Page: 202-210
Author(s): Pradum Pundlikrao Ige, Nilesh Ashok Bachhav, Hitendra Shaligram Mahajan, Pankaj Padmakar Nerkar, Surendra Ganeshlal Gattani

Novel Microwell-Based Spectrophotometric Assay for the Determination of Rosuvastatin Calcium in its Pharmaceutical Formulations

Journal: Current Pharmaceutical Analysis
Volume: 9 Issue: 1 Year: 2013 Page: 54-60
Author(s): Tanveer A. Wani, Ibrahim A. Darwish, Nasr Y. Khalil

The Current Role of Statin Therapy in the Treatment of Atrial Fibrillation

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2013 Page: 9-13
Author(s): Franjo Naji,Miso Sabovic

Journal: Current Medicinal Chemistry
Volume: 20 Issue: 1 Year: 2013 Page: 1397-1408
Author(s): E. Matteucci, O. Giampietro

Cytochrome P450 2C8 and Drug Metabolism

Journal: Current Topics in Medicinal Chemistry
Volume: 13 Issue: 18 Year: 2013 Page: 2241-2253
Author(s): Xiaoping Lv,Fangfang Zhong,Xiangshi Tan

New Aspects of Statin Safety

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 13 Issue: 2 Year: 2013 Page: 97-106
Author(s): Hisashi Makino, Mariko Harada-Shiba

Rationale of Statin Therapy in Septic Patients

Journal: Current Vascular Pharmacology
Volume: 11 Issue: 5 Year: 2013 Page: 795-800
Author(s): Mariusz Piechota, Marcin Barylski, Simon Hannam, Magdalena Piechota-Urbańska, Maciej Banach

Pharmacological Approaches to Chronic Spinal Cord Injury

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 24 Year: 2013 Page: 4423-4436
Author(s): Inge Steuer,Pascal Rouleau,Pierre A. Guertin

Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia and other Pathologies

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3161-3172
Author(s): Nabil G. Seidah

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and LDL Lowering in the Contemporary Management of Dyslipidemia

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2013 Page: 281-288
Author(s): Maryna Popp Switzer,Azikiwe C. Nwosu,Zinnia San Juan,Debabrata Mukherjee